Finance

Lists
OBIO:NASDAQ
Orchestra Biomed Holdings Inc
US$ ५.७२
+१.३३%
(+०.०७५) 1D
अक्टोबर १५, १२:५४:१८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OBIO...
Open
US$ ५.६८
High
US$ ५.८५
Low
US$ ५.६६
Mkt. cap
३४.३५ करोड
Avg. vol.
३.४० लाख
Volume
८८.७८ हजार
52-wk high
US$ ६.५०
52-wk low
US$ ३.२६
EPS
-US$ १.०१
Beta
०.५२
Shares outstanding
६.०१ करोड
No. of employees
८६
Open
US$ ५.६८
High
US$ ५.८५
Low
US$ ५.६६
Mkt. cap
३४.३५ करोड
Avg. vol.
३.४० लाख
Volume
८८.७८ हजार
52-wk high
US$ ६.५०
52-wk low
US$ ३.२६
EPS
-US$ १.०१
Beta
०.५२
Shares outstanding
६.०१ करोड
No. of employees
८६
News stories
From web sources and news partners
About Orchestra Biomed Holdings Inc
CEO-
Employees८६
Founded२०१८
Headquarters-
Sector-
Websiteorchestrabiomed.com
Analyst ratings
Based on 5 analysts giving stock ratings to OBIO in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OBIO in the last 3 months.
Highest
Current US$ ५.७२
US$ १५.०० (+१६२.४७%)
Average
US$ ११.६० (+१०२.९७%)
Lowest
US$ १०.०० (+७४.९८%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew O'Brien
Piper Sandler
Buy
Maintained
US$ १२.००
+११०%
10/15/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ १०.००
+७५%
10/05/2026
Madison Elsaadi
B. Riley Securities
Buy
Reiterated
US$ ११.००
+९२.५%
10/02/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$ १५.००
+१६२.५%
09/25/2026
Marie Thibault
BTIG
Buy
Upgraded
US$ १०.००
+७५%
09/10/2026
Unknown Analyst
BTIG
Hold
Maintained
-
-
07/09/2026
Anderson Schock
B. Riley Securities
Buy
Reiterated
US$ १०.००
+७५%
05/18/2026
Matt Miksic
Barclays
Buy
Reiterated
US$ १३.००
+१२७.५%
05/13/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$ २०.००
+२५०%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
८.६१ लाख
३.०९ करोड
१.१० लाख
८८.०० हजार
Cost of goods sold
४९.०० हजार
५१.०० हजार
३२.०० हजार
२५.०० हजार
Cost of revenue
४९.०० हजार
५१.०० हजार
३२.०० हजार
२५.०० हजार
Research and development expenses
१.४० करोड
१.६८ करोड
१.५८ करोड
१.६६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७०.९८ लाख
७२.८९ लाख
६३.७३ लाख
५८.२९ लाख
Operating expense
२.११ करोड
२.४१ करोड
२.२२ करोड
२.२४ करोड
Total operating expenses
२.१२ करोड
२.४२ करोड
२.२२ करोड
२.२४ करोड
Operating income
-२.०३ करोड
६७.५४ लाख
-२.२१ करोड
-२.२४ करोड
Other non operating income
-
२.५४ लाख
-३.७६ लाख
-५.१७ लाख
EBT including unusual items
-२.०८ करोड
६२.४५ लाख
-२.०७ करोड
-२.३८ करोड
EBT excluding unusual items
-२.०८ करोड
६२.४५ लाख
-२.२९ करोड
-२.३८ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.०८ करोड
६२.४५ लाख
-२.०७ करोड
-२.३८ करोड
Net profit margin
-२,४१९.०५%
२०.२०%
-१८,८१०.००%
-२६,९९४.३२%
Earnings per share
-०.४०
०.२६
-०.३३
-०.३७
Interest and investment income
-
७.५२ लाख
-
-
Interest expense
-५.१५ लाख
-१५.१५ लाख
-४.८० लाख
-९.२७ लाख
Net interest expenses
-५.१५ लाख
-७.६३ लाख
-४.८० लाख
-९.२७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.०२ करोड
६८.३६ लाख
-२.२० करोड
-२.२३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू